Cooperative Research Center for NanoScaffold-Based Chlamydia trachomatis Vaccines - Admin Core
基于纳米支架的沙眼衣原体疫苗合作研究中心 - 管理核心
基本信息
- 批准号:10458650
- 负责人:
- 金额:$ 28.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-08 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Chlamydia trachomatis (Ct) is the most common bacterial sexually transmitted infection (STI),
affecting over 130 million people every year, and is the most common cause of preventable
blindness worldwide. In the United States, STIs caused by C. trachomatis account for billions of
dollars in annual costs. Because the infection can be asymptomatic, it may go untreated for years
and can result in long-term sequelae, including pelvic inflammatory disease, chronic abdominal
pain, ectopic pregnancy, and infertility. Ct is an intracellular bacterial pathogen widespread
throughout the world. In order to address the critical need for a C. trachomatis vaccine, the
Administrative Core will be responsible for managing, coordinating, monitoring overall
progress, and supervising the entire range of the center's activities, including the Developmental
Research Program (DRP). This will involve coordination of work between three primary sites:
LLNL, UCI and UCD with an emphasis on developing young scientist and novel technologies to
mitigate health effects associated with C. trachomatis. The Core will focus on the following four
areas: 1) Provide coordination to facilitate interactions among the CRC Project PIs and Core
Directors. 2) To ensure internal data sharing and an external site for scientific outreach. 3)
Establish and administrate the Developmental Research Program. 4) Evaluate the Center's
progress utilizing internal and external advisory reviews.
项目摘要/摘要
沙眼衣原体(CT)是最常见的细菌性传播感染(STI),
每年影响超过1.3亿人,这是可预防的最常见原因
全球盲目。在美国,由C. c. trachomatis造成的性传播感染占数十亿美元
年度费用。因为感染可能是无症状的,所以它可能没有治疗多年
并可能导致长期后遗症,包括骨盆炎性疾病,慢性腹部
疼痛,异位妊娠和不育。 CT是一种细胞内的细菌病原体
全世界。为了解决对沙眼梭状芽胞盘疫苗的关键需求,
行政核心将负责管理,协调,监视整体监控
进步并监督中心活动的整个范围,包括发展
研究计划(DRP)。这将涉及三个主要站点之间的工作协调:
LLNL,UCI和UCD着重于发展年轻科学家和新颖技术
减轻与沙眼梭状芽孢杆菌相关的健康影响。核心将重点关注以下四个
区域:1)提供协调以促进CRC项目和核心之间的相互作用
导演。 2)确保内部数据共享和科学外展的外部站点。 3)
建立和管理发展研究计划。 4)评估中心的
利用内部和外部咨询评论的进步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Matthew Adrian Col...的其他基金
Induction of cross C. trachomatis serovar protection utilizing a polyvalent nanoparticle vaccine.
利用多价纳米颗粒疫苗诱导交叉沙眼衣原体血清型保护。
- 批准号:1045865610458656
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatis
项目1.纳米脂蛋白支持的沙眼衣原体多亚单位疫苗
- 批准号:1022311410223114
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Induction of cross C. trachomatis serovar protection utilizing a polyvalent nanoparticle vaccine.
利用多价纳米颗粒疫苗诱导交叉沙眼衣原体血清型保护。
- 批准号:1022311510223115
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
减轻沙眼衣原体发病机制的生物启发纳米支架中心
- 批准号:1045864910458649
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Project 1. Nanolipoprotein-supported multi-subunit vaccine for Chlamydia trachomatis
项目1.纳米脂蛋白支持的沙眼衣原体多亚单位疫苗
- 批准号:1045865410458654
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
减轻沙眼衣原体发病机制的生物启发纳米支架中心
- 批准号:1022310810223108
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Cooperative Research Center for NanoScaffold-Based Chlamydia trachomatis Vaccines - Admin Core
基于纳米支架的沙眼衣原体疫苗合作研究中心 - 管理核心
- 批准号:1022311010223110
- 财政年份:2019
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Synthetic Generation of a Chlamydia Vaccine
衣原体疫苗的合成生成
- 批准号:93077289307728
- 财政年份:2016
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Characterization of Erbb Receptors in Nanoparticles
纳米颗粒中 Erbb 受体的表征
- 批准号:85048018504801
- 财政年份:2011
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Characterization of Erbb Receptors in Nanoparticles
纳米颗粒中 Erbb 受体的表征
- 批准号:88599588859958
- 财政年份:2011
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
相似海外基金
Characterizing the genetic etiology of delayed puberty with integrative genomic techniques
利用综合基因组技术表征青春期延迟的遗传病因
- 批准号:1066360510663605
- 财政年份:2023
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Social Vulnerability, Sleep, and Early Hypertension Risk in Younger Adults
年轻人的社会脆弱性、睡眠和早期高血压风险
- 批准号:1064314510643145
- 财政年份:2023
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
ACTS (AD Clinical Trial Simulation): Developing Advanced Informatics Approaches for an Alzheimer's Disease Clinical Trial Simulation System
ACTS(AD 临床试验模拟):为阿尔茨海默病临床试验模拟系统开发先进的信息学方法
- 批准号:1075367510753675
- 财政年份:2023
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Unraveling how Lipophilic Modulators Alter pLGIC Function via Interactions with the M4 Transmembrane Helix
揭示亲脂性调节剂如何通过与 M4 跨膜螺旋相互作用改变 pLGIC 功能
- 批准号:1078575510785755
- 财政年份:2023
- 资助金额:$ 28.61万$ 28.61万
- 项目类别:
Testing Approaches to Promote Breast Cancer Screening in Rural Ghana
促进加纳农村地区乳腺癌筛查的测试方法
- 批准号:1064544610645446
- 财政年份:2023
- 资助金额:$ 28.61万$ 28.61万
- 项目类别: